T1	Participants 146 170	coronary heart diseases.
T2	Participants 753 910	Amiloride and Optimal Medical Therapy (OMT, n=35 cases) vs OMT alone (n=35 cases) in patients having angina, ST-T alteration and a defective RBC-K transport.
T3	Participants 911 1059	All patients had serial clinical evaluation, Ion Transport Studies, ECGs and non-invasive aortic waveform and cardiovascular hemodynamic recordings.
T4	Participants 2080 2138	the heart, in patients receiving optimal medical treatment
